[9] For wound healing specifically, the evidence is stronger than for cosmetic anti-aging, because wound models involve measurable endpoints (wound closure rate, tissue tensile strength, histological analysis) in controlled animal studies
But behind the buzz is a more important question: Are these products safe, effective and backed by evidence
To ensure temporality between GLP-1 RA use and SUD onset, we established the observation window from January 1, 2005 (the year of initial GLP-1 RA approval) to February 24, 2025, based on the most recent data available from the AoU dataset
WEDNESDAY, June 10, 2026 (HealthDay News) Another GLP-1 pill could be headed for the market soon, according to early clinical trial results